University of Surrey

Test tubes in the lab Research in the ATI Dance Research

A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.

Sooriakumaran, P, Macanas-Pirard, P, Bucca, G, Henderson, A, Langley, SE, Laing, RW, Smith, CP, Laing, EE and Coley, HM (2009) A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. Cancer Genomics Proteomics, 6 (2). 93 - 99. ISSN 1109-6535

[img]
Preview
PDF
Sooriakumaran_2009.pdf
Available under License : See the attached licence file.

Download (100Kb)
[img]
Preview
PDF (licence)
SRI_deposit_agreement.pdf

Download (32Kb)

Abstract

We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis.

Item Type: Article
Additional Information: Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. Reproduced here by permission of the publisher.
Uncontrolled Keywords: Base Sequence, Cyclooxygenase Inhibitors, DNA Primers, DNA, Complementary, Gene Expression Profiling, Humans, Male, Oligonucleotide Array Sequence Analysis, Polymerase Chain Reaction, Prostatic Neoplasms, Pyrazoles, Single-Blind Method, Sulfonamides
Divisions: Faculty of Health and Medical Sciences > Microbial and Cellular Sciences
Depositing User: Symplectic Elements
Date Deposited: 23 Apr 2012 08:43
Last Modified: 23 Sep 2013 19:11
URI: http://epubs.surrey.ac.uk/id/eprint/203293

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800